MDLN
Medline Inc.
$41.04
Stable Earnings Power
80%
P/Adj-EPS × Normalized Multiple
Moderate
·
Conviction
Fair Value
Trading 15.3% below fair value
You pay
$41.04
Bear
$38.74
Fair
$48.43
Bull
$58.12
Bear
$38.74
-5.6%
$2.95 × 13x P/E
Fair
$48.43
+18.0%
$2.95 × 16x P/E
Bull
$58.12
+41.6%
$2.95 × 20x P/E
Key Value Driver
Normalized P/E multiple (16x base case)
Implied Market Multiple
13.9x
Summary
Our base-case estimate uses a valuation based on adjusted earnings per share and a normalized price-to-earnings multiple. We then blend that result with the average analyst price target of $48.55 from 14 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $48.43 per share.
Warnings
The company's reported profits differ from official accounting profits by 107%. Check what costs are being left out of the adjusted number.
Key Risks
- Growth DCF inappropriate — terminal value assumptions dominate
- EV/EBITDA misleading for regulated businesses where capex is mandated
- Regulatory risk is a fat tail not visible in normal multiples